Compare NN & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NN | LMAT |
|---|---|---|
| Founded | 2007 | 1983 |
| Country | United States | United States |
| Employees | 103 | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.6B |
| IPO Year | N/A | 2006 |
| Metric | NN | LMAT |
|---|---|---|
| Price | $18.71 | $109.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $25.00 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 3.1M | 136.2K |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 2.52 |
| Revenue | N/A | ★ $249,602,000.00 |
| Revenue This Year | N/A | $14.21 |
| Revenue Next Year | N/A | $8.88 |
| P/E Ratio | ★ N/A | $42.41 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $10.84 | $78.01 |
| 52 Week High | $24.19 | $118.01 |
| Indicator | NN | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 52.66 | 46.89 |
| Support Level | $13.32 | $81.85 |
| Resistance Level | $19.91 | $113.40 |
| Average True Range (ATR) | 1.91 | 3.25 |
| MACD | -0.15 | -0.93 |
| Stochastic Oscillator | 39.20 | 25.54 |
NextNav Inc provides GPS service. The company NextNav TerraPoiNT system delivers resilient, next-generation, complementary positioning, navigation, and timing (PNT) solutions designed to overcome the limitations and vulnerabilities of existing space-based Global Navigation Satellite Systems (GNSS), including the Global Positioning System (GPS). The products of the company include NextNav Pinnacle: Accurate vertical location, NextNav 3D: 3D location visualization, NextNav TerraPoiNT: Resilient PNT for 3D and indoor geolocation, Next Generation Solution: Terrestrial 3D PNT powered by spectrum.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.